{"title":"Application of antisense technology to urologic cancers.","authors":"Y. Tomita","doi":"10.1089/10915360050138594","DOIUrl":null,"url":null,"abstract":"Antisense oligodeoxynucleotides (ODNs) inhibit target gene expression and are applicable to human diseases including malignancies. Although improvements in ODNs and cellular delivery systems are needed, antisense ODNs hold great promise as a new class of therapeutic agents.","PeriodicalId":80296,"journal":{"name":"Molecular urology","volume":"4 2 1","pages":"55-9"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/10915360050138594","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/10915360050138594","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Antisense oligodeoxynucleotides (ODNs) inhibit target gene expression and are applicable to human diseases including malignancies. Although improvements in ODNs and cellular delivery systems are needed, antisense ODNs hold great promise as a new class of therapeutic agents.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
